| The Parkinson's progression markers initiative (PPMI) - establishing a PD biomarker cohort |
40 |
| Brain-computer interfaces for post-stroke motor rehabilitation: a meta-analysis |
37 |
| Neurofilament light chain serum levels correlate with 10-year MRI outcomes in multiple sclerosis |
32 |
| Environmental and genetic risk factors for MS: an integrated review |
28 |
| Diabetes and obesity are the main metabolic drivers of peripheral neuropathy |
28 |
| Influenza-like illness as a trigger for ischemic stroke |
26 |
| Genetic landscape and novel disease mechanisms from a large LGMD cohort of 4656 patients |
26 |
| Neurofilament as a potential biomarker for spinal muscular atrophy |
26 |
| A multicenter real-world review of 10 kHz SCS outcomes for treatment of chronic trunk and/or limb pain |
24 |
| A prospective open-label trial of a CBD/THC cannabis oil in dravet syndrome |
19 |
| Safety, pharmacodynamics, and potential benefit of omaveloxolone in Friedreich ataxia |
19 |
| Lifelong behavioral and neuropathological consequences of repetitive mild traumatic brain injury |
18 |
| alpha-synuclein RT-QuIC in cerebrospinal fluid of LRRK2-linked Parkinson's disease |
15 |
| Blood neurofilament light as a potential endpoint in Phase 2 studies in MS |
15 |
| Immunotherapy with ponezumab for probable cerebral amyloid angiopathy |
14 |
| Phenotypic heterogeneity in m.3243A > G mitochondrial disease: The role of nuclear factors |
14 |
| alpha-Synuclein RT-QuIC assay in cerebrospinal fluid of patients with dementia with Lewy bodies |
13 |
| Abnormal fatty acid metabolism is a core component of spinal muscular atrophy |
13 |
| Serum neurofilament light chain levels associations with gray matter pathology: a 5-year longitudinal study |
12 |
| A new counterintuitive training for adult amblyopia |
12 |
| Novel CSF biomarkers in genetic frontotemporal dementia identified by proteomics |
12 |
| Association of corneal nerve fiber measures with cognitive function in dementia |
12 |
| Acoustic enhancement of sleep slow oscillations in mild cognitive impairment |
12 |
| Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectory |
12 |
| Rapamycin prevents cerebral stroke by modulating apoptosis and autophagy in penumbra in rats |
11 |
| Is seizure frequency variance a predictable quantity? |
11 |
| Plasma alpha-synuclein detected by single molecule array is increased in PD |
11 |
| Natural history of limb girdle muscular dystrophy R9 over 6 years: searching for trial endpoints |
11 |
| The NRF2 pathway as potential biomarker for dimethyl fumarate treatment in multiple sclerosis |
11 |
| Long-term Phase 1/2 intraspinal stem cell transplantation outcomes in ALS |
11 |
| Immunosuppressants and risk of Parkinson disease |
11 |
| The impact of rituximab infusion protocol on the long-term outcome in anti-MuSK myasthenia gravis |
10 |
| Autoimmune postural orthostatic tachycardia syndrome |
10 |
| Placebo-controlled crossover assessment of mecasermin for the treatment of Rett syndrome |
10 |
| Targeting potassium channels to treat cerebellar ataxia |
10 |
| Physiological and pathological high frequency oscillations in focal epilepsy |
10 |
| Poly(GP), neurofilament and grey matter deficits in C9orf72 expansion carriers |
9 |
| Genomic analysis identifies masqueraders of full-term cerebral palsy |
9 |
| Polygenic risk and hazard scores for Alzheimer's disease prediction |
9 |
| Agreement of amyloid PET and CSF biomarkers for Alzheimer's disease on Lumipulse |
9 |
| Prolonged-release melatonin in patients with idiopathic REM sleep behavior disorder |
9 |
| Seronegative antibody-mediated neurology after immune checkpoint inhibitors |
9 |
| Design and results of a smartphone-based digital phenotyping study to quantify ALS progression |
9 |
| Exploring mTOR inhibition as treatment for mitochondrial disease |
9 |
| Diagnostic Potential of Neural Exosome Cargo as Biomarkers for Acute Brain Injury |
9 |
| Combined transcranial magnetic stimulation in the treatment of chronic tinnitus |
9 |
| Remote ischemic conditioning for acute stroke patients treated with thrombectomy |
9 |
| Cognitive and functional connectivity alterations in Friedreich's ataxia |
8 |
| Whole-exome sequencing in 197 persons for rare variants in Alzheimer's disease |
8 |
| CCL2 and CXCL10 are associated with poor outcome after intracerebral hemorrhage |
8 |
